- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 16.25M sh |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $638.4M |
| Long Term Debt | Q1 2025 · Mar 31, 2024 | $507.9M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $105.8M |
| Short Term Debt | Q1 2025 · Mar 31, 2024 | $169.9M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $6.3M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $512.5M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $510.8M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $489.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $228.7M |
| Current Liabilities | Q1 2025 · Mar 31, 2024 | $276.6M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $188.8M |
| Current Assets | Q1 2025 · Mar 31, 2024 | $189.4M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.79B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $1.7B |
| Stock Issued | Q1 2025 · Mar 31, 2024 | 5.8K sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.1M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $6.8M |
| Capex | Q1 2025 · Mar 31, 2024 | $20.2M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $26.6M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.69 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.69 |
| Net Income | Q1 2025 · Mar 31, 2024 | $27.2M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $44.2M |
| Revenue | Q1 2025 · Mar 31, 2024 | $178.7M |